Cargando…

The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms

The age-related decrease in skeletal muscle mass together with the loss of muscle power and function is defined sarcopenia. Mounting evidence suggests that the prevalence of sarcopenia is higher in patients with type 2 diabetes mellitus (T2DM), and different mechanisms may be responsible for this as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massimino, Elena, Izzo, Anna, Riccardi, Gabriele, Della Pepa, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393336/ https://www.ncbi.nlm.nih.gov/pubmed/34440727 http://dx.doi.org/10.3390/cells10081958

Ejemplares similares

A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
por: Izzo, Anna, et al.
Publicado: (2021)

Risk of Sarcopenia and Associated Factors in Older Adults with Type 2 Diabetes: An Exploratory Cross-Sectional Study
por: Massimino, Elena, et al.
Publicado: (2023)

Wholegrain Intake and Risk of Type 2 Diabetes: Evidence from Epidemiological and Intervention Studies
por: Della Pepa, Giuseppe, et al.
Publicado: (2018)

Protein and Leucine Intake at Main Meals in Elderly People with Type 2 Diabetes
por: Massimino, Elena, et al.
Publicado: (2023)

Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
por: Kwak, Ju Yeon, et al.
Publicado: (2019)

Fruitarian Diet and Blood Glucose Control in Type 1 Diabetes: A Case Report
por: Vetrani, Claudia, et al.
Publicado: (2022)

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
por: Infante, Marco, et al.
Publicado: (2022)

Diet Quality, Cardiometabolic Risk and Diabetes
por: Della Pepa, Giuseppe
Publicado: (2023)

Focus on Nutritional Aspects of Sarcopenia in Diabetes: Current Evidence and Remarks for Future Research
por: Göbl, Christian, et al.
Publicado: (2022)

Autoimmunity as a novel mechanism underlying sarcopenia
por: Zhang, Tan
Publicado: (2023)

Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
por: Rubio-Ruiz, María Esther, et al.
Publicado: (2019)

Current evidence on the role of lipid lowering drugs in the treatment of psoriasis
por: Wang, Jiao, et al.
Publicado: (2022)

Vitamin E in Sarcopenia: Current Evidences on Its Role in Prevention and Treatment
por: Khor, Shy Cian, et al.
Publicado: (2014)

Nutrition and Muscle Strength, As the Key Component of Sarcopenia: An Overview of Current Evidence
por: Robinson, Sian, et al.
Publicado: (2019)

Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine
por: Tecce, Nicola, et al.
Publicado: (2020)

Association between Diet Quality and Index of Non-Alcoholic Steatohepatitis in a Large Population of People with Type 2 Diabetes: Data from the TOSCA.IT Study
por: Vitale, Marilena, et al.
Publicado: (2022)

Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review
por: Jang, Jung Yoon, et al.
Publicado: (2023)

Pharmacogenetics of novel glucose-lowering drugs
por: Rathmann, Wolfgang, et al.
Publicado: (2021)

Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia
por: Kanova, Marcela, et al.
Publicado: (2022)

Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial
por: Della Pepa, Giuseppe, et al.
Publicado: (2020)

Sarcopenia in Menopausal Women: Current Perspectives
por: Buckinx, Fanny, et al.
Publicado: (2022)

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
por: Fonseca, Vivian A, et al.
Publicado: (2010)

The Triglycerides and Glucose (TyG) Index Is Associated with 1-Hour Glucose Levels during an OGTT
por: Massimino, Mattia, et al.
Publicado: (2022)

Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus
por: Ogama, Noriko, et al.
Publicado: (2019)

Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms
por: Cho, Jinkyung, et al.
Publicado: (2020)

Investigation of the Underlying Mechanism of Sclerosteosis Expression in Muscle Tissue in Multiple Myeloma with Sarcopenia
por: Ren, Jie, et al.
Publicado: (2023)

Exploring molecular mechanisms underlying the pathophysiological association between knee osteoarthritis and sarcopenia
por: Yang, Jiyong, et al.
Publicado: (2023)

Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia
por: Ma, Xiao-Yu, et al.
Publicado: (2021)

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)

Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2018)

Current Understanding of Sarcopenia and Malnutrition in Geriatric Rehabilitation
por: Nishioka, Shinta
Publicado: (2023)

Current Nutritional and Pharmacological Approaches for Attenuating Sarcopenia
por: Sakuma, Kunihiro, et al.
Publicado: (2023)

Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
por: den Ouden, Henk, et al.
Publicado: (2016)

UTILIZATION TRENDS OF NEWLY APPROVED GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES
por: Dave, Chintan, et al.
Publicado: (2019)

The Common Mechanisms of Sarcopenia and NAFLD
por: Zhai, Yu, et al.
Publicado: (2017)

Triticum vulgare Extract and Polyhexanide (Fitostimoline(®) Hydrogel/Fitostimoline(®) Plus Gauze) versus Saline Gauze Dressing in Patients with Diabetic Foot Ulcers: Results of a Randomized Controlled Trial
por: Della Pepa, Giuseppe, et al.
Publicado: (2023)

Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis
por: Jingi, Ahmadou M., et al.
Publicado: (2017)

Legume Consumption and Blood Pressure Control in Individuals with Type 2 Diabetes and Hypertension: Cross-Sectional Findings from the TOSCA.IT Study
por: Vitale, Marilena, et al.
Publicado: (2023)

Current Status of Sarcopenia in the Disabled Elderly of Chinese Communities in Shanghai: Based on the Updated EWGSOP Consensus for Sarcopenia
por: Fang, Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pq0j9sgfv6tknm4hskuntkdkki